For in vitro diagnostic use. Others Elecsys Syphilis IVD Elecsys® Syphilis CPS_000515 09 015 051 162 9 015 051 162 09015051162 9015051162 09015051162 Syphilis Elecsys E2G 20 x 300 Elecsys Syphilis 07613336183083 Reagents, kits 20x300 tests cobas pro serology solution true 09 015 051 190 9 015 051 190 09015051190 9015051190 09015051190 Syphilis Elecsys E2G 300 V2 Elecsys Syphilis 07613336171998 Reagents, kits 300 tests cobas e 402/801 true 09 014 977 190 9 014 977 190 09014977190 9014977190 09014977190 Syphilis Elecsys cobas e 100 V2 Elecsys Syphilis 07613336171950 Reagents, kits 100 tests cobas e 411/601/602 true 09015051501 Elecsys Syphilis en 2 FF00000005D1860E FF000000050B1C0E 09015051190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative detection of total antibodies (IgG and IgM) to Treponema pallidum in human serum and plasma. The test is intended as an aid in the diagnosis of syphilis infection in conjunction with clinical signs and symptoms.The Elecsys Syphilis immunoassay is not intended for use in screening blood or tissue donors. The effectiveness of this assay in testing blood or tissue donors has not been established.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09014977501 Elecsys Syphilis en 2 FF00000006E8140E FF0000000564660E 09014977190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative detection of total antibodies (IgG and IgM) to Treponema pallidum in human serum and plasma. The test is intended as an aid in the diagnosis of syphilis infection in conjunction with a nontreponemal laboratory test and clinical signs and symptoms.The Elecsys Syphilis immunoassay is not intended for use in screening blood or tissue donors. The effectiveness of this assay in testing blood or tissue donors has not been established.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en

Immunoassay for the qualitative determination of total antibodies against Treponema pallidum

Intended to aid in the diagnosis of syphilis infection in conjunction with nontreponemal tests and clinical signs and symptoms

Syphilis is caused by the intracellular Gram-negative spirochete bacterium Treponema pallidum subspecies pallidum.¹ In 2023, over 200,000 new cases were reported in the US, the greatest number of cases since 1950.²

Most people with syphilis are asymptomatic, but if untreated the infection can cause significant complications.³ Although syphilis is usually transmitted sexually, it can also be transmitted from mother to fetus with over 3,700 pregnancies affected in the US each year.⁴ However, if diagnosed in the early stages, syphilis can be successfully treated and congenital syphilis prevented.^5,6

Serologic tests like the Elecsys^® Syphilis assay are the method of choice for the reliable detection of total antibodies against Treponema pallidum in clinical routine samples.⁷

User Profile

Select your user profile

Elecsys^® Syphilis

Immunoassay for the qualitative determination of total antibodies against Treponema pallidum

Intended to aid in the diagnosis of syphilis infection in conjunction with nontreponemal tests and clinical signs and symptoms